Studies have shown that CKb11 gene therapy has a significant anti-ovarian cancer effect and stimulates immune cells to secrete a large amount of IFN-γ while mediating immune activation and tumor eradication [16]. This evidence concerns the gene CCL19 and ovarian carcinoma.